Arthur McElroy v. Janssen Pharmaceutica

Eighth Circuit

Arthur McElroy v. Janssen Pharmaceutica

282 F. App'x 510

CourtCourt of Appeals for the Eighth Circuit

DecidedJuly 1, 2008

Docket07-2277

StatusUnpublished

This text of 282 F. App'x 510 (Arthur McElroy v. Janssen Pharmaceutica) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Arthur McElroy v. Janssen Pharmaceutica, 282 F. App'x 510 (8th Cir. 2008).

Pincite

Opinion

PER CURIAM.

Arthur McElroy appeals the district court’s 1 Federal Rule of Civil Procedure 12(b)(6) dismissal of his pro se products-liability claims against Janssen Pharmaceutica, Inc. and Janssen Pharmaceutica, N.V. 2 Upon de novo review, see Reis v. Walker, 491 F.3d 868, 870 (8th Cir.2007), we conclude that dismissal was proper for the reasons stated by the district court.

Accordingly, the judgment is affirmed, see 8th Cir. R. 47B, and appellees’ pending motion is denied.

1

. The Honorable Richard G. Kopf, United States District Judge for the District of Nebraska.

2

. McElroy's claim against Eli Lilly Pharmaceutical Company is not at issue in this appeal.

Free access — add to your briefcase to read the full text and ask questions with AI